Ad is loading...
ENVB
Price
$0.36
Change
-$0.03 (-7.50%)
Updated
Nov 15 closing price
130 days until earnings call
PRQR
Price
$3.82
Change
-$0.13 (-3.29%)
Updated
Nov 15 closing price
101 days until earnings call
Ad is loading...

ENVB vs PRQR

Header iconENVB vs PRQR Comparison
Open Charts ENVB vs PRQRBanner chart's image
Enveric Biosciences
Price$0.36
Change-$0.03 (-7.50%)
Volume$337.17K
CapitalizationN/A
ProQR Therapeutics
Price$3.82
Change-$0.13 (-3.29%)
Volume$924.51K
CapitalizationN/A
ENVB vs PRQR Comparison Chart
Loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ENVB vs. PRQR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a Sell and PRQR is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ENVB: $0.37 vs. PRQR: $3.82)
Brand notoriety: ENVB and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 51% vs. PRQR: 52%
Market capitalization -- ENVB: $3.26M vs. PRQR: $404.56M
ENVB [@Biotechnology] is valued at $3.26M. PRQR’s [@Biotechnology] market capitalization is $404.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 0 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENVB and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 6 bullish TA indicator(s).

  • ENVB’s TA Score: 4 bullish, 6 bearish.
  • PRQR’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PRQR is a better buy in the short-term than ENVB.

Price Growth

ENVB (@Biotechnology) experienced а -22.67% price change this week, while PRQR (@Biotechnology) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ENVB is expected to report earnings on Mar 27, 2025.

PRQR is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($405M) has a higher market cap than ENVB($3.26M). PRQR YTD gains are higher at: 92.929 vs. ENVB (-71.923). ENVB has higher annual earnings (EBITDA): -11.71M vs. PRQR (-17.31M). PRQR has more cash in the bank: 96.2M vs. ENVB (3.5M). ENVB has less debt than PRQR: ENVB (0) vs PRQR (19.2M). PRQR has higher revenues than ENVB: PRQR (15.4M) vs ENVB (0).
ENVBPRQRENVB / PRQR
Capitalization3.26M405M1%
EBITDA-11.71M-17.31M68%
Gain YTD-71.92392.929-77%
P/E RatioN/AN/A-
Revenue015.4M-
Total Cash3.5M96.2M4%
Total Debt019.2M-
FUNDAMENTALS RATINGS
ENVB vs PRQR: Fundamental Ratings
ENVB
PRQR
OUTLOOK RATING
1..100
5316
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
9335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (15) in the Electronics Or Appliances industry is somewhat better than the same rating for PRQR (76) in the Biotechnology industry. This means that ENVB’s stock grew somewhat faster than PRQR’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ENVB’s stock grew similarly to PRQR’s over the last 12 months.

PRQR's SMR Rating (95) in the Biotechnology industry is in the same range as ENVB (98) in the Electronics Or Appliances industry. This means that PRQR’s stock grew similarly to ENVB’s over the last 12 months.

PRQR's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for ENVB (93) in the Electronics Or Appliances industry. This means that PRQR’s stock grew somewhat faster than ENVB’s over the last 12 months.

PRQR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that PRQR’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBPRQR
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRQR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WB8.350.15
+1.83%
Weibo Corp
TDUP0.92-0.01
-0.58%
ThredUp
ACON0.16-0.01
-3.88%
Aclarion
MREO3.53-0.29
-7.59%
Mereo BioPharma Group plc
BIO320.31-29.92
-8.54%
Bio-Rad Laboratories IncClass A

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-8.06%
PRQR - ENVB
43%
Loosely correlated
-3.29%
ALNY - ENVB
36%
Loosely correlated
-8.67%
PSTX - ENVB
34%
Loosely correlated
-14.02%
ORMP - ENVB
33%
Poorly correlated
-4.50%
SLNCF - ENVB
28%
Poorly correlated
N/A
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-3.29%
KRRO - PRQR
49%
Loosely correlated
-4.31%
ATNF - PRQR
47%
Loosely correlated
-6.72%
WVE - PRQR
44%
Loosely correlated
-8.87%
ENVB - PRQR
43%
Loosely correlated
-8.06%
LOGC - PRQR
32%
Poorly correlated
+1.67%
More